Package 70010-785-09

{"route": ["ORAL"], "spl_id": "43786649-9a7c-20ad-e063-6294a90a13fe", "openfda": {"upc": ["0370010785038", "0370010784031"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["d9eb0939-63c1-48c4-a444-a899d7924d06"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-785-03)", "package_ndc": "70010-785-03", "marketing_start_date": "20221215"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-785-05)", "package_ndc": "70010-785-05", "marketing_start_date": "20221215"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-785-09)", "package_ndc": "70010-785-09", "marketing_start_date": "20221215"}], "brand_name": "Bupropion hydrochloride", "product_id": "70010-785_43786649-9a7c-20ad-e063-6294a90a13fe", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70010-785", "generic_name": "Bupropion hydrochloride", "labeler_name": "Granules Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA215568", "marketing_category": "ANDA", "marketing_start_date": "20221215", "listing_expiration_date": "20261231"}